GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Sale Of Investment

3SBio, (FRA:YFK) Sale Of Investment : €78.5 Mil (TTM As of Dec. 2016)


View and export this data going back to . Start your Free Trial

What is 3SBio, Sale Of Investment?

3SBio,'s sale of investment for the six months ended in Dec. 2016 was €70.6 Mil. It means 3SBio, gained €70.6 Mil from selling investments. 3SBio,'s sale of investment for the trailing twelve months (TTM) ended in Dec. 2016 was €78.5 Mil.

Compared with last quarter (€7.9 Mil in Jun. 2016 ), 3SBio, gained more money from selling investments in Dec. 2016 (€70.6 Mil).

3SBio, Sale Of Investment Historical Data

The historical data trend for 3SBio,'s Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Sale Of Investment Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.58 61.28 - 9.96 78.65

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.29 9.68 7.95 70.59

3SBio, Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was €78.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3SBio, Sale Of Investment Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio, (FRA:YFK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Sale Of Investment
Comparable Companies
RFL ROCO:3176 APLT CABA SRRK GRTX OSMT UBX TPE:4142 GRTS OYST SZSE:002286 CRBP TSE:7774 ROCO:6712 SZSE:002868 CDMO SZSE:002898 UROV KIN
Traded in Other Exchanges
N/A
Address
Website
http://www.3sbio.com
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines